Technology · 05/11/20261 min read
Medical Devices; Neurological Devices; Classification of the Prognostic Assessment Software of Mild Cognitive Impairment
Summary
The Food and Drug Administration (FDA) is classifying the prognostic assessment software of mild cognitive impairment into class II (special controls).
Original source language: Federal Register — Health and Human ServicesOpen original release →